With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Join Dr. George Honos as he presents the details of the CCS-accredited series of live symposia Hot Topics in Cardiology: Ripped from The Headlines, talking place across Canada in June 2012.
Dr. Rader and his panel of experts, Drs. Davidson, Fazio, Orringer, and Underberg, examine the latest data on the metabolism, function, quantification, and modulation of HDL-C.
Join Drs. Underberg and Waters as they discuss dyslipidemia in patients with HIV and the appropriate selection of statin therapy to avoid drug-drug interactions.
Join Drs. Fuster, Barter, and Toth as they discuss the challenges of identifying statin intolerance in elderly patients and how to manage it effectively.
Join our experts Drs. Ballantyne, Schaefer, Miller, and Bays as they discuss perspectives from AHA 2011 meeting on improving the standard of care for patients with dyslipidemia.
Join Drs. Foody and Dall as they discuss managing statin intolerance, drug-drug interactions, and statin therapy selection in patients with dyslipidemia.
Join Dr. Robert Rosenson for a case-based discussion of CV risk assessment, management tools, and reduction strategies that go beyond the standard lipid panel.
Dr. Derek Fine reviews 2 cases: a 60-year-old man with type 2 diabetes, hypertension, and retinopathy; and a 58-year-old woman with hypertension and suspected CKD.
Review how dyslipidemia contributes to cardiovascular risk and apply strategies to individualize therapies that improve outcomes for patients with dyslipidemia, including those with comorbidities that confound treatment.
Cardiovascular events occur despite patients having on-treatment LDL-C levels within the recommended range. You are invited to participate in this educational survey to gauge physician practice patterns in the management of dyslipidemia.
Discuss the epidemiology of cardiovascular disease in high-risk, chronic renal disease patients and review state of the practice data that shows that treating high risk can provide a benefit
In 2009, NLA members identified HDL-C management as one of their top 5 educational needs to be addressed. In this CME activity, Dr. Peter Toth reviews the latest advances for the management of HDL-C.
Learn about Dyslipidemia clinical condition. This new resource center provides key articles, slide kits and support material to physicians and healthcare providers of patients with dyslipidemia, plus information and data you may not easily find elsewhere! Learn more about Dyslipidemia. Supported by an independent educational grant from Abbott.
This Education center is a virtual venue for in-depth information, tools, and support material for physicians and healthcare providers involved in the care of patients presenting with any risk factor related to metabolic syndrome.
Show all
Collapse